COMPU DAWN INC
S-3/A, 1998-11-20
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: PACIFICARE HEALTH SYSTEMS INC /DE/, 8-K/A, 1998-11-20
Next: METAWAVE COMMUNICATIONS CORP, RW, 1998-11-20



   
    As filed with the Securities and Exchange Commission on November 20, 1998
                           Registration No. 333-65303
    

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                 AMENDMENT NO. 1
                                       TO
                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933


                                COMPU-DAWN, INC.
             (Exact Name of Registrant as Specified in Its Charter)

                       Delaware                              11-3344575
(State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification 
                                                Number)

                                77 Spruce Street
                           Cedarhurst, New York 11516
                            Telephone: (516) 374-6700
                           Telecopier: (516) 374-9410
    (Address, Including Zip Code, and Telephone Number, Including Area Code,
                  of Registrant's Principal Executive Offices)

                                 Mark Honigsfeld
                            Chairman of the Board and
                             Chief Executive Officer
                                Compu-DAWN, Inc.
                                77 Spruce Street
                           Cedarhurst, New York 11516
                            Telephone: (516) 374-6700
                           Telecopier: (516) 374-9410
            (Name, Address, Including Zip Code, and Telephone Number,
                   Including Area Code, of Agent For Service)


                  Copies of all communications and notices to:

                               Fred Skolnik, Esq.
                              Gavin C. Grusd, Esq.
                       Certilman Balin Adler & Hyman, LLP
                                90 Merrick Avenue
                           East Meadow, New York 11554
                            Telephone: (516) 296-7000
                           Telecopier: (516) 296-7111



<PAGE>



                  Approximate  date  of  commencement  of  proposed  sale to the
                  public:  As soon as  practicable  after the effective  date of
                  this Registration Statement.

                  If the only securities being registered on this form are being
                  offered pursuant to dividend or interest  reinvestment  plans,
                  please check the following box. [ ]

                  If any of the securities  being registered on this form are to
                  be offered on a delayed or continuous  basis  pursuant to Rule
                  415 of the  Securities  Act of  1933,  other  than  securities
                  offered  only  in   connection   with   dividend  or  interest
                  reinvestment plans, check the following box. [x]

                  If this form is filed to register additional securities for an
                  offering  pursuant to Rule 462(b)  under the  Securities  Act,
                  please check the  following  box and list the  Securities  Act
                  registration   statement  number  of  the  earlier   effective
                  registration statement for the same offering. [ ]

                  If this form is a  post-effective  amendment filed pursuant to
                  Rule 462(c) under the Securities  Act, check the following box
                  and list the Securities Act  registration  statement number of
                  the  earlier  effective  registration  statement  for the same
                  offering. [ ]

                  If delivery of the prospectus is expected to be made pursuant 
                  to Rule 434, please check the following box. [ ]

                         CALCULATION OF REGISTRATION FEE
<TABLE>

====================================================================================================================================
                                                                                                      Proposed
                                                                             Proposed Maximum          Maximum
                                                      Amount to be             Offering Price   Aggregate Offering     Amount of
Title of Each Class of Securities to be Registered     Registered                Per Share (4)       Price (4)      Registration Fee
- ------------------------------------------------------------------------------------------------------------------------------------


Common Stock, $.01 par value per share, issuable  
<S>                                                   <C>                        <C>                <C>                    <C>    
upon conversion of Series A Convertible                1,300,000(1)               $1.50          $1,950,000.00         $575.25
Preferred Stock, registered for the benefit of
Selling Stockholders

Common Stock, $.01 par value per share, issuable  
upon conversion of Series B Convertible                  327,103(2)                $1.50           $490,654.50         $144.74
Preferred Stock, registered for the benefit of
Selling Stockholders

Common Stock, $.01 par value per share, issuable          180,414(3)               $1.50           $270,621.00          $79.83
upon exercise of outstanding warrants

Common Stock, $.01 par value per share,                   125,000                  $1.50           $187,500.00          $55.31
registered for the benefit
of Selling Stockholders

   
Common Stock, $.01 par value per share, issuable           75,000                  $2.44           $183,000.00          $50.87
under certain circumstances, registered for benefit
of Selling Stockholders                                                                                                
    

                      Total Registration Fee:                                                                           $ 906.00 (5)

================================================================================================================================    


</TABLE>


<PAGE>



(1)               For purposes of estimating the number of the Company's  shares
                  of Common Stock to be included in this Registration Statement,
                  the Company  calculated 200% of the number of shares of Common
                  Stock issuable upon the conversion at maturity of 3,250 shares
                  of the Company's Series A Convertible  Preferred  Stock,  $.01
                  par value per share  (the  "Series  A  Stock"),  or  otherwise
                  pursuant to the Certificate of  Designations,  Preferences and
                  Rights of the Series A Stock,  based on a conversion  price of
                  $5.00 per share.  Pursuant to Rule 416  promulgated  under the
                  Securities Act of 1933, as amended (the "Securities Act"), the
                  number of shares of Common  Stock to be  registered  hereunder
                  also  includes  an  indeterminate  number of shares  which may
                  become issuable upon conversion,  of or otherwise with respect
                  to,  the  Series A Stock to prevent  dilution  resulting  from
                  stock splits, stock dividends or similar transactions.

(2)               Pursuant to Rule 416 promulgated under the Securities Act, the
                  number of shares of Common  Stock to be  registered  hereunder
                  also  includes  an  indeterminate  number of shares  which may
                  become  issuable upon  conversion  of the  Company's  Series B
                  Convertible  Preferred  Stock,  $.01 per value per  share,  to
                  prevent dilution resulting from stock splits,  stock dividends
                  or similar transactions.

(3)               For purposes of estimating the number of the Company's  shares
                  of Common Stock to be included in this Registration Statement,
                  the Company  calculated 200% of the number of shares of Common
                  Stock  issuable upon the exercise of warrants for the purchase
                  of 90,207 shares of Common Stock based upon an exercise  price
                  of $8.025 per share.  Pursuant to Rule 416  promulgated  under
                  the Securities Act, the number of shares of Common Stock to be
                  registered  hereunder also includes an indeterminate number of
                  shares which may become issuable upon exercise of the warrants
                  to  prevent  dilution  resulting  from  stock  splits,   stock
                  dividends or similar transactions.

(4)               Estimated solely for the purpose of calculating the amount of 
                  the registration fee pursuant to Rule 457(c).

   
(5)               Of which $855.13 was previously paid.
    


                  The registrant  hereby amends this  Registration  Statement on
such date or dates as may be  necessary  to delay its  effective  date until the
registrant shall file a further  amendment which  specifically  states that this
Registration  Statement  shall  thereafter  become  effective in accordance with
Section 8(a) of the Securities Act or until this  Registration  Statement  shall
become effective on such date as the Securities and Exchange Commission,  acting
pursuant to said Section 8(a), may determine.




<PAGE>



   
         The  information in this Prospectus is not complete and may be changed.
We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This Prospectus is not an offer
to sell these  securities and is not soliciting an offer to buy these securities
in any state where the offer or sale is not permitted.
    


                                   PROSPECTUS

                                ----------------

                                COMPU-DAWN, INC.

   
                        2,007,517 SHARES OF COMMON STOCK



The  shares  of common  stock  offered  by this  Prospectus  are  being  sold by
stockholders  of  Compu-DAWN,  Inc.  See  "Selling  Stockholders"  and  "Plan of
Distribution."  A purchase of these  securities  involves a high degree of risk.
See "Risk Factors," beginning on page 5.

                 The common stock of Compu-DAWN, Inc. is traded
             on the Nasdaq SmallCap Market under the symbol "CODI."



Neither  the  Securities  and  Exchange  Commission  nor  any  state  securities
commission has approved or disapproved of these securities or determined if this
Prospectus  is truthful or  complete.  Any  representation  to the contrary is a
criminal offense.
    





                                Compu-DAWN, Inc.
                                77 Spruce Street
                           Cedarhurst, New York 11516
                                 (516) 374-6700



                                                                , 1998



<PAGE>



NO  DEALER,  SALESMAN  OR ANY  OTHER  PERSON  HAS  BEEN  AUTHORIZED  TO GIVE ANY
INFORMATION OR TO MAKE ANY  REPRESENTATION NOT CONTAINED IN THIS PROSPECTUS AND,
IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATION  MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY THE COMPANY OR ANY OTHER PERSON.  THIS PROSPECTUS DOES
NOT CONSTITUTE AN OFFER TO SELL OR A  SOLICITATION  OF AN OFFER TO BUY TO ANYONE
IN ANY  JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT AUTHORIZED OR IN
WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT QUALIFIED TO DO SO, OR
TO ANYONE TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NEITHER THE
DELIVERY  OF THIS  PROSPECTUS  NOR ANY SALE  MADE  HEREUNDER  SHALL,  UNDER  ANY
CIRCUMSTANCES,  CREATE ANY IMPLICATION THAT ANY INFORMATION  CONTAINED HEREIN IS
CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF.



                              AVAILABLE INFORMATION

                  The Company files reports,  proxy and  information  statements
and  other  information  with  the  Securities  and  Exchange   Commission  (the
"Commission").  Such  reports,  statements  and other  information  filed by the
Company with the Commission can be inspected and copied at the public  reference
facilities  maintained by the Commission at Judiciary  Plaza,  450 Fifth Street,
N.W.,  Washington,  D.C.  20549 and at the  following  Regional  Offices  of the
Commission:  7 World Trade Center,  Suite 1300,  New York,  New York 10048;  and
Citicorp  Center,  500  West  Madison  Street,  Suite  1400,  Chicago,  Illinois
60661-2511.  Copies  of such  material  can also be  obtained  from  the  Public
Reference Section of the Commission at Judiciary Plaza, 450 Fifth Street,  N.W.,
Washington,  D.C.  20549  at  prescribed  rates.  Furthermore,   the  Commission
maintains a Web site that contains reports, proxy and information statements and
other  information  regarding  the  Company.  The  address  of such  Web site is
http://www.sec.gov.




                                        2

<PAGE>



                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

   
         The  documents  listed  below have been filed by  Compu-DAWN,  Inc.,  a
Delaware  corporation (the "Company"),  with the Commission under the Securities
Exchange Act of 1934,  as amended (the  "Exchange  Act"),  and are  incorporated
herein by reference:
    

                 (a)The  Company's  Annual  Report on Form 10-KSB for the fiscal
                    year ended December 31, 1997 (the "Form 10-KSB").

                 (b)The Company's  Quarterly Report on Form 10-QSB for the three
                    months ended March 31, 1998.

                 (c) The  Company's  Current  Report  on Form  8-K for an event
                    dated April 22, 1998.
     
                 (d) The  Company's  Current  Report  on Form  8-K for an event
                    dated April 23, 1998.

                 (e)The Company's  Current Report on Form 8-K for an event dated
                    June 8, 1998.

                 (f)The Company's  Quarterly Report on Form 10-QSB for the three
                    months ended June 30, 1998.

                 (g)The Company's  Current Report on Form 8-K for an event dated
                    September 1, 1998.

                 (h)The Company's  Current Report on Form 8-K for an event dated
                    September 25, 1998.

   
                 (i)The Company's  Quarterly Report on Form 10-QSB for the three
                    months ended September 30, 1998.

                 (j)The Company's  Current Report on Form 8-K for an event dated
                    November 18, 1998.

                 (k)The  description of the Company's  Common Stock contained in
                    the Company's  Registration  Statement on Form 8-A (File No.
                    000-22611),  which was declared  effective by the Commission
                    on June 10, 1997.

         All documents filed by the Company  pursuant to Sections 13(a),  13(c),
14 or 15(d) of the Exchange Act after the date of this Prospectus,  and prior to
the  termination of the offering of the 2,007,517  shares of common stock,  $.01
par value  per share  ("Common  Stock"),  of the  Company  offered  hereby  (the
"Shares"),  shall be deemed to be incorporated by reference into this Prospectus
and to be a part hereof from their respective dates of filing.
    


                                        3

<PAGE>



         The Company will provide  without  charge to each person to whom a copy
of this  Prospectus is  delivered,  upon the written or oral request of any such
person, a copy of any or all of the documents  referred to above which have been
incorporated  into this  Prospectus  by reference  (other than  exhibits to such
documents).  Requests  for such  copies  should be  directed  to the  Secretary,
Compu-DAWN,  Inc.,  77 Spruce  Street,  Cedarhurst,  New York  11516  (telephone
number: (516) 374-6700).

         Any statement contained in a document  incorporated herein by reference
shall be deemed to be modified or superseded for purposes of this  Prospectus to
the extent  that a  statement  contained  herein  modifies  or  supersedes  such
statement.  Any statement so modified or superseded shall not be deemed,  except
as so modified or superseded, to constitute a part of this Prospectus.

                                   THE COMPANY

         Compu-DAWN,  Inc. (the "Company") is primarily  engaged in the business
of designing, developing,  licensing, installing and servicing computer software
products  and  systems  for law  enforcement  and public  safety  agencies.  The
software systems include computer-aided  dispatching,  computer interfacing with
state and national crime  information  databases,  advanced mobile on-line radio
computing,  automatic vehicle location (employing dynamic map displays), records
management  and  photo-image  database  systems.  Certain of these  applications
utilize   telecommunications   and  space   satellite   technology,   and  other
infrastructure,  provided by third parties. The Company has developed,  licensed
and installed its systems in approximately 60 agencies  primarily located in the
State of New York.

         The Company was incorporated  under the name Coastal Computer  Systems,
Inc. in New York on March 31, 1983 and was  reincorporated in Delaware under its
present name on October 18, 1996.

         The  Company's  executive  offices  are  located  at 77 Spruce  Street,
Cedarhurst, New York 11516 and its telephone number is (516) 374-6700.

                           FORWARD-LOOKING STATEMENTS

         Certain  information  contained herein and/or incorporated by reference
in this Prospectus includes  "forward-looking  statements" within the meaning of
the Private Securities Litigation Reform Act of 1995, and is subject to the safe
harbor created by that act. The Company cautions readers that certain  important
factors may affect the Company's  actual results and could cause such results to
differ  materially from any  forward-looking  statements  which may be deemed to
have been made in this Prospectus or which are otherwise made by or on behalf of
the Company.  For this purpose, any statements contained in this Prospectus that
are not  statements  of  historical  fact may be  deemed  to be  forward-looking
statements.  Without  limiting the  generality of the  foregoing,  words such as
"may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate,"
or "continue" or the negative  variations thereof or comparable  terminology are
intended to identify

                                        4

<PAGE>



forward-looking  statements.  Factors  which may  affect the  Company's  results
include, but are not limited to, the risks and uncertainties associated with the
level of spending by law  enforcement  and public  safety  agencies for computer
application  software  and  hardware,  the  competitive  environment  within the
industry,  the ability of the Company to expand its  operations,  the competence
required,  and  experience,  of management to effectuate the Company's  business
plan,  the level of costs  incurred in  connection  with the  Company's  planned
expansion efforts,  economic conditions in the industry,  the financial strength
of the Company's customers and suppliers,  and unascertainable  risks related to
possible  unspecified  acquisitions.  The Company is also subject to other risks
detailed  herein  or  detailed  from  time to time in the  Company's  Commission
filings.  Factors that could cause or contribute to such difference include, but
are not limited to, those  discussed in "Risk Factors"  below,  as well as those
discussed  elsewhere in this  Prospectus  and in the Company's  filings with the
Commission.

                                  RISK FACTORS

   
         An  investment  by you in the  shares  offered  by this  Prospectus  is
speculative  and involves a high degree of risk.  You should only purchase these
securities  if you can afford to lose your entire  investment.  Before making an
investment,  you should  carefully  consider the following risks and speculative
factors,  as well as the other  information  contained  in this  Prospectus.  As
discussed  above,  this  Prospectus  contains  forward-looking  statements  that
involve risks and uncertainties.  The actual results of the Company's operations
could  be  significantly  different  from  the  information  contained  in those
forward-looking statements. Those differences could result from the risk factors
discussed  immediately  below,  as well as factors  discussed in other places in
this Prospectus.

         In this "Risk  Factors"  section,  "we," "our" and "ours"  refer to the
Company, and "you," "your" and "yours" refer to a purchaser of the shares of the
Company offered by this Prospectus.

       1.       Lack of Significant Revenues; Historical and Anticipated Losses.


      Period Ended                         Revenues                   Net Loss


December 31, 1996 (year)                   $ 477,527               $   570,769

December 31, 1997 (year)                     591,375                 4,436,745

September 30, 1998 (nine months)             916,129                 1,266,910


         The table  above sets out our  revenues  and net losses for the periods
indicated  in the first  column.  The net losses  are the result of  significant
expenses,  including research and development  expenses,  enhancing and refining
our  product  line,  marketing  costs,  employment  agreement  costs and general
administrative  expenses.  In  addition,  the 1997 loss  reflects  approximately
$1,588,000 in non-recurring  deferred  financing  charges incurred in connection
with a debt offering we made.
    

                                        5

<PAGE>



   
Furthermore,  the net loss  figure for 1998 was  higher  than it would have been
otherwise  because  we did not  generate  significant  revenues,  but did  incur
expenses regarding  contemplated  business ventures.  We believe that we will be
unable  to  achieve  revenues  sufficient  to  offset  operating  costs  for the
foreseeable future; therefore, we anticipate that operating losses will continue
for at least the next 12 months.  We cannot  predict  how long  these  operating
losses will  continue or what impact they will have on our  financial  condition
and results of operations. We cannot assure you that our technology and products
will be able to  compete  successfully  in the  marketplace  or that  they  will
generate  significant  revenue;  nor can we assure you that our business will be
able to operate profitably.

         Our  operating  results have varied  widely in the past from quarter to
quarter,  and may  continue  to.  Factors  such as (a) the  amount,  timing  and
recognition of revenue from significant  sales or other business  activity,  (b)
the timing of new product releases and market  acceptance of these new releases,
and (c)  increases in operating  expenses,  will all affect  quarterly  results.
Conversely,  with the fixed nature of costs such as personnel and facilities,  a
decline in revenues in any one quarter typically results in lower  profitability
for that quarter.  We cannot assure you that we will become  profitable or avoid
losses in any future period.

         2.   Evolving   Market;   New   Product   Development;    Technological
Obsolescence.  Our  ability  to  compete  will  depend on our  ability to adapt,
enhance  and improve  our  existing  products  and  technology,  and develop and
introduce new products and technology in a timely and cost- competitive manner.

         The markets for our software products are characterized by

                -  evolving industry requirements
                -  rapid technological change
                -  frequent introductions of new products

Any one of these factors may result in product or technology obsolescence. Other
companies may be developing technologies or products of which we are unaware and
which may be similar or superior to some or all of the products  and  technology
we  offer.  We  cannot  predict  whether  or not our  competitors  will  develop
technologies or products that will render ours obsolete or less  marketable,  or
whether  we will be able to  enhance  and  adapt  our  products  and  technology
successfully.

         All  the  risks  inherent  in the  development  of new  technology  and
products,  including unanticipated delays, expenses and technical problems, will
accompany our new product development  efforts. We cannot assure you that (a) we
can develop additional  technologies within a reasonable  schedule;  (b) we will
have sufficient economic or human resources to complete such development; (c) we
will have access to sufficient  funding to complete  development;  or (d) we can
make economically  reasonably arrangements for the completion of new products by
third parties.
    

                                        6

<PAGE>



   
Therefore,  we can make no assurances as to when, or whether,  new products will
be successfully developed.

         Before we can  market  any  additional  product,  we must  successfully
complete a testing  program for it.  Although we believe our testing  program is
adequate,  unforseen  technical  problems arising out of the testing process may
delay or prevent  our  production  or  marketing  of a  commercially  acceptable
product.  In addition,  our current and proposed products must meet the cost and
performance  demands  of  the  marketplace.   We  cannot  assure  you  that  new
technologies  or products  will be developed by us, or that,  if they are,  they
will meet  cost and  performance  objectives;  neither  can we  assure  you that
unforseen technical problems (or other problems) will not significantly increase
the cost, or delay the introduction, of such products. Furthermore, as discussed
in the first paragraph of this section,  if superior  technology is developed by
our competitors, it may render our products obsolete and thus have a significant
negative impact on us.

         3. Failure to Integrate Various Product Introductions and Offerings. To
compete  successfully,  we must be able to integrate our software  products with
other  systems.  We have  achieved  some success with  integration  in the past,
although we cannot guarantee that we will continue to do so either with existing
applications  or  newly  created  applications.  If we  are  unable  to  further
integrate our  products,  there could be a  significant  negative  effect on our
business; even if we do achieve further integration,  there is no guarantee that
we will improve our competitive position in the software market.

         4. Product  Concentration.  In 1996,  1997 and the first nine months of
1998,  almost all of our  revenues  came from the  licensing of products and the
provision of  maintenance  and support  services to law  enforcement  and public
safety agencies. A shift in the needs of these customers, or the introduction of
superior competitive  products, or any circumstance which would adversely affect
the narrow area in which our products are concentrated, would have a significant
negative effect on our financial condition and results of operations.

         5. Lengthy  Sales Cycle.  The public  agencies  that buy or license our
products  usually  have a long  internal  approval  procedure,  due to the large
expense and the  significant  change to the  customer's  infrastructure  that is
represented by a purchase from us. These internal acceptance  procedures as well
as the customer's budgetary constraints are beyond our control.  Therefore,  the
sales cycle  associated  with our products is typically  quite long. Due to this
lengthy sales cycle and the generally large size of customer orders, if revenues
forecast  from a specific  customer  for a specific  quarter are not realized in
that  quarter,  our  operating  results  for that  quarter  could be  materially
adversely affected.

         6.   Competition.   Our   products   compete  with  those  of  numerous
well-established  companies.  Many of these companies have substantially greater
financial,  technical  and  other  resources  than  we do,  and  they  may  have
established  reputations  for success in the  development,  licensing,  sale and
service of their products and  technology.  Some of these  competitors  have the
financial resources to withstand substantial price competition,  or downturns in
the  market for the  products  we  produce.  In  addition,  we  anticipate  that
significant sales of our products will be made
    

                                        7

<PAGE>



   
through the competitive  bidding  process.  We cannot be certain that we will be
able to compete against these companies effectively in such a process.

         7.  Limited  Sales and  Marketing  Infrastructure.  The  Company  has a
limited  sales,  marketing  and  distribution  infrastructure.   Our  sales  and
marketing  staff must be expanded.  We cannot be certain that we will be able to
build an adequate sales and marketing staff,  that we will be able to do it in a
cost-effective  manner,  or  that  our  sales  and  marketing  efforts  will  be
successful.

         8. Dependence on Significant Customers.  We have, so far, depended on a
limited  number of customers for the bulk of its  revenues.  Although the actual
customers  have  changed  from year to year,  generally  the number of customers
remains small.  We generally do not receive  repeat  business from customers for
whom we have designed and installed  software systems.  Any additional  revenues
from these customers are usually derived from maintenance and support contracts.
With this history, we do not believe that the makeup of our current customers is
important to an  understanding  of our future  business  prospects.  Although we
expect  our  customer  base to  continue  to expand,  a limited  number of large
customers  may continue to represent a  significant  portion of our sales during
any  given  period  for the  foreseeable  future.  Consequently,  our  financial
condition and results of operations may be adversely affected by the loss of one
or  more of  these  customers,  or by  such a  customer's  reduction,  delay  or
cancellation of orders.

         9.  Dependence  on  Strategic   Business  Alliances  and  Subcontractor
Relationships.  To enter the "large size" market  segment for our  products,  we
will   probably  need  to  establish   strategic   business   alliances   and/or
subcontractor  relationships  with large systems  integrators and public network
providers.

         Our customers  have, so far, been in the "small size" and "medium size"
market segments (i.e., fewer than 200 sworn officers or personnel). Our business
strategy  includes the  development of systems for the large size market and the
establishment of relationships to help us enter that market.

         Business alliances have been entered into with AT&T Wireless Data, Inc.
("AT&T") and GTE MobileNet  Service Corp.  ("GTE").  These  arrangements  do not
relate to a particular customer; they govern the relationship between us and the
other  party for a system  installation  for a mutual  customer.  The  agreement
between us and AT&T provides for, among other things,  minimum technical support
standards  and minimum  revenue  requirements.  If we do not meet the  technical
support standards, AT&T is entitled to reduce the technical support fees paid to
us; the minimum  revenue  requirements  may entitle us to a goal attainment fee.
Failure to meet the minimum revenue requirements  entitles AT&T to terminate the
agreement.  The agreement with GTE allows GTE to not pay us during any period in
which we fail to materially perform our obligations.

       We cannot be certain that, if any projects are undertaken with AT&T, GTE 
or Data  General,  we  will  meet  the  required  standards, revenue  levels, or
obligations. If not, our compensation may be reduced or eliminated and the early
termination of these agreements is a possibility. Furthermore,
    

                                        8

<PAGE>



   
we cannot be certain that we will renew these  agreements  or enter into others.
Our inability to maintain or enter into business alliances and/or  subcontractor
relationships would significantly  hinder our implementation of the "large size"
market plan.

         10. Intellectual  Property Protection and Infringement.  Our technology
is not patented and we have not filed any patent applications.  We rely on trade
secrets and copyright rights to establish and protect certain proprietary rights
in our products. These measures give limited protection, and it is possible that
they will be inadequate to protect proprietary rights, prevent  misappropriation
of our technology,  or prevent the independent  development by others of similar
technology. This potential inadequacy is compounded by our limited resources and
the potential cost of legal action to enforce our rights.

         We have not obtained any  copyright  registrations.  We believe that it
would be impractical and not cost-effective for a third party to attempt to copy
software  like that used in our  products.  Still,  unauthorized  parties  might
attempt to copy or reverse-engineer all or parts of our products,  or may obtain
information that we regard as proprietary.

         Registration of a copyright with the United States  Copyright office is
not a  requirement  to  make a  copyright  legally  effective.  However,  such a
registration  generally  reinforces the registrant's  claim. In the absence of a
registered   copyright,   we  will  be  unable  to  sue  anyone  for   copyright
infringement.  A  copyright  may be  registered  at any time  prior to suing for
infringement.  If a copyright is registered before infringement  occurs, the law
permits the injured party to recover certain amounts of money even if the actual
harm that's been suffered  equal a smaller  amount of money.  If we register the
copyright after the infringement occurs (and before suing), we may be limited in
our ability to prove our case and in the amount we can  recover as damages.  The
cost of enforcement by us of our rights could be significant;  nevertheless,  we
can give no assurance that such proceedings will be effective.

         We believe there are no infringement  or trade secret  misappropriation
claims  against us and that there are no grounds for the  assertion  of any such
claims; however, should such a claim be made, the cost of responding to it could
be significant and we cannot be certain that we would prevail.

         11. Dependence on Executive  Management;  Need to Retain Key Personnel.
Our  executive  management  team consists of Mark  Honigsfeld,  our Chairman and
Chief Executive Officer, and Louis Libin, our Chief Technology Officer.

     The loss of the services of either Mr. Honigsfeld or Mr. Libin could have a
significantly  detrimental effect on our business. We have three-year employment
agreements  with  Messrs.   Honigsfeld  and  Libin.   Each  agreement   includes
non-competition and non-solicitation  provisions.  However,  each agreement also
provides  that the employee can terminate it at any time upon 30 days notice for
any reason.  Additionally,  Mr. Honigsfeld's  employment agreement allows him to
devote
    

                                        9

<PAGE>



   
up to 10% of his working time to other endeavors that are not competitive with 
us.  Mr. Libin's employment agreement allows him to devote up to one day a week 
to such endeavors.

         We have  obtained  "key-man"  life  insurance  policies on the lives of
Messrs.  Honigsfeld  and  Libin,  each of which  policies  provides  for a death
benefit to us of  $1,000,000.  We cannot be certain that the death benefit would
be adequate to fund our needs until a successor could be found.

         Our  success  is also  partly  dependent  upon our  ability to hire and
retain additional  personnel.  Qualified and talented  executive,  technical and
marketing  personnel  are  always  in  great  demand  in our  business,  and our
inability to recruit them could have a materially adverse impact on our business
and results of operations.  We cannot say with certainty that we will be able to
retain our current  management  or other  personnel,  or that we will be able to
attract and retain qualified  personnel in management,  engineering and sales in
the future.

         12. Dependence on Licensors. We rely on operating system software owned
by  unaffiliated  third  parties for certain  software  and  platform  operating
systems  which we use to create our  products,  and in some cases to bundle with
our own software.  The licenses under which we use this software require payment
of either an annual  maintenance and enhancement fee, or of a monthly sublicense
fee. An annual fee is based on the number of end users of the  operating  system
software;  a monthly  fee is based  upon the  number of  customers  to which our
products  are  licensed  (including  products  where such  licensed  software is
included).  We  believe  that there are  alternatives  to the  operating  system
software that we currently use, and that we could revise our software to make it
compatible with these alternatives.  However,  termination of any of the current
licenses could result in production delays of approximately three to six months;
these delays would have a material adverse effect on our business.

         13.  Challenges  to  Management  of Growth.  We  anticipate a period of
growth as a result of the development of our software  business that is expected
to strain our administrative,  financial and operational resources.  Our ability
to manage growth effectively will require us to

            -     continue to improve our operational,  financial and management
            -     controls  continue to improve reporting systems and procedures
            -     install new management  information and control systems train,
            -     motivate and manage our employees

We cannot be certain that we will achieve improvements or install new management
systems in an efficient  and timely  manner,  or that the  improvements  and new
systems will be adequate to support our  operations.  Additionally,  many of the
challenges  of growth will be  unforeseeable  and beyond our control.  If we are
unable to  manage  growth  effectively,  resulting  in our  sales and  marketing
efforts exceeding our capacity to design, develop, install, maintain and service
our products,  or if new employees  are unable to achieve  adequate  performance
levels,  our  business,  operating  results  and  financial  condition  could be
negatively influenced.
    


                                       10

<PAGE>



   
         Due to the  complexity of our software  products,  we have  experienced
(and expect to experience  again) a time lag between the date on which technical
and sales personal are hired and the time at which they become fully productive.
Customer  satisfaction  could be  substantially  affected  by the quality of our
post-sales  system  implementation  process and, in many cases,  by our software
maintenance and service capabilities. If we are unable to hire, train and retain
qualified  personnel  and  consultants  to perform  these  services,  or fail to
supervise the  post-sales  process  effectively,  our ability to attract  repeat
sales or obtain references for prospective  sales could be negatively  impacted.
Such results could limit our growth opportunities.

         14. Matters Relating to Terminated Agreement.  On September 1, 1998, we
terminated an agreement we had entered into with Rugby National Corp. ("Rugby").
We had entered  into an Agreement  and Plan of Merger (the  "Merger  Agreement")
with Rugby  regarding the right to operate a national  online lottery in Russia.
The  Merger  Agreement  contained  conditions  to our  obligation  to close  the
transaction;  since these  conditions  had not been  satisfied  by the  deadline
(August 31, 1998), we terminated the Merger Agreement.  Subsequently,  Rugby and
its  counsel  claimed  that we had  breached  certain  provisions  of the Merger
Agreement.  We believe that we have legitimate  defenses against Rugby's claims.
Rugby has not begun any lawsuit yet;  however,  if it does,  we intend to defend
ourselves vigorously.

         The Merger  Agreement  provided for "liquidated  damages" if we did not
close the Merger Agreement even though the conditions to our obligation to close
were  met.  The  maximum  amount  payable  to Rugby  as  liquidated  damages  is
$1,000,000;  but,  since we had  loaned  approximately  $125,000  to Rugby,  our
potential   liability  would  be  the  difference  between  that  loan  and  the
$1,000,000. We do not believe we have any liability for liquidated damages.

         We estimate  that the total cost to us of the Merger  Agreement and the
related transactions was approximately  $300,000, all of which has been included
as an expense in our financial statements.

         15. Risks Related to Possible  Unspecified  Acquisitions.  We intend to
explore opportunities to:

              -   add technology or products to our current product line
              -   acquire a customer base or sales  organization  to augment our
                     infrastructure  
              -  make and/or market products not in our current line of business

The Board of Directors will decide whether any  opportunity to add technology or
products is in the best interest of our stockholders.  We cannot be certain that
any such opportunities will arise, or that, if they do, we will be able to reach
an agreement on terms  acceptable to us.  Furthermore,  if any such  opportunity
involves the acquisition of a business, we cannot be certain that:

               -  we will successfully  integrate the operations of the acquired
               -  business  with  ours  all  the  benefits  expected  from  such
               -  integration will be realized
    

                                       11

<PAGE>



   
               -  delays or unexpected costs related to the integration will not
                     have a detrimental affect on our combined business,  
                     operating results or  financial  condition  
               -   our  respective  operations, management  and personnel  
                      will be compatible
               -   we will not lose key personnel

In most cases, an acquisition will be concluded without stockholder approval, in
which case our stockholders will not have an opportunity to review the financial
statements of the  acquisition  candidate.  Although we will attempt to evaluate
the risks  inherent in a  particular  acquisition,  we cannot be certain that we
will properly ascertain or assess such significant risk factors.

         If we acquire  technology or products in the early stage of development
or growth  (including  technology or products that have not been fully tested or
marketed),  we will be subject  to  numerous  risks  inherent  in  developmental
technology,  plus  the  additional  high  level  of risk  associated  with  high
technology industries.  Furthermore, these acquisitions may require us to obtain
additional financing from banks or other financial  institutions or to undertake
debt or equity  financing.  We cannot  assure you that we will be able to obtain
financing  on  commercially  reasonable  terms  or at all.  Furthermore,  equity
financing  will result in a dilution to our  existing  stockholders,  i.e.,  the
number  of  shares  that you own will  represent  a  smaller  percentage  of our
outstanding  stock.  The degree of dilution may be  significant.  In the case of
debt financing, we run the risks of interest rate fluctuations and insufficiency
of cash flow to pay principal and interest, along with other risks traditionally
associated with incurring indebtedness.

         16.  International  Expansion.  Although  we  have  not  developed  any
international marketing strategy or given significant attention to international
marketing,  we do intend to explore  opportunities to expand our operations into
international  markets.  Such an expansion could require significant  management
attention  and  financial  resources.  In  addition,  there are  risks  that are
peculiar to international sales and operations, including:

            -   potentially   longer  payment  cycles  
            -   unexpected  changes  in  regulatory  requirements  
            -   import and export  restrictions  and tariffs   
            -   difficulties   in  staffing  and  managing foreign operations  
            -   compliance with foreign laws 
            -   greater difficulty in collecting   accounts   receivable  
            -   potentially  adverse  tax consequences  
            -   currency  fluctuations  
            -   potential  political and economic   instability   
            -   cultural differences relating  to day-to-day business operations

Additionally,  protecting intellectual property can be more difficult and costly
outside the United States. If we expand internationally, price controls or other
restrictions  on  foreign  currencies  could  have a  significant  affect on our
business, operating results and financial condition.
    


                                       12

<PAGE>



   
         17. Control By Existing Management and Stockholders;  Effect of Certain
AntiTakeover  Considerations.  Our directors and executive officers beneficially
own approximately 29% of our outstanding Common Stock. The holders of our Series
A Convertible Preferred Stock ("Series A Stock"), Series B Convertible Preferred
Stock  ("Series  B  Stock")  and  certain  warrants  held by such  holders  (the
"Warrants")  currently may not convert or exercise  their  securities to acquire
more than 4.99% of our outstanding  Common Stock.  Each of the holders may waive
that limitation. If all of them waive the limitation,  the holders of the Series
A Stock,  the  Series  B Stock  and the  Warrants  have  the  right  to  acquire
approximately  27% of the  Common  Stock  that  would be  outstanding  following
conversion  or  exercise  of  their  securities.   Thus,  these  two  groups  of
stockholders,  if acting  together,  have the potential voting strength to exert
significant  influence over the election of our directors and over other matters
submitted to our  stockholders  for  approval.  (The  percentages  given in this
paragraph  do not  account  for some of the rights  given to the  holders of the
Series A and Series B Stock and the Warrants.  There is  additional  information
about  the  conversion  of the  Series A Stock  and the  Series B Stock  and the
exercise of the  Warrants in the section of this  Prospectus  entitled  "Selling
Stockholders.")

         We may issue additional Preferred Stock without approval of the holders
of Common Stock. If we issue Preferred  Stock, it could discourage a third party
from buying a majority of our  outstanding  Common Stock.  This, in turn,  could
prevent our  stockholders  from selling their shares at a price above the market
price.  The rights that the holders of Common Stock have will be subject to, and
may be negatively  affected by, the rights that holders of Preferred Stock might
be given.  In addition,  our being  governed by a staggered  Board of Directors,
certain  provisions of our By-Laws,  and certain provisions of Delaware Law that
are  applicable  to us all could delay or  complicate a merger,  tender offer or
proxy contest involving us.

         18.  Impact  of Nasdaq  SmallCap  Market  Rules.  Our  Common  Stock is
currently traded on the Nasdaq SmallCap Market.  If we are unable to satisfy the
requirements for continued quotation on that market, trading of our Common Stock
would be conducted in the over-the-counter  market, in what is commonly referred
to as the "pink sheets" or on the NASD OTC Electronic Bulletin Board.

         For continued listing on the Nasdaq SmallCap Market, we are required to
have, among other things, all of the following:

             - either   net   tangible   assets   of   $2,000,000,   or   market
               capitalization of $35,000,000,  or net income for two of the last
               three  fiscal  years of $500,000  
             - minimum  market value or public float of $1,000,000 
             - minimum bid price of $1.00 per share

Nasdaq also  requires  that we have at least two  independent  directors  and an
Audit Committee, a majority of whose members must also be independent directors.
    


                                       13

<PAGE>



   
         If you buy the Common Stock offered by this  Prospectus  and our Common
Stock is  afterwards  traded  only in the  "pink  sheets"  or on the  Electronic
Bulletin  Board,  you may find it more  difficult  to  dispose  of the shares or
obtain accurate quotations as to their price.

         19. Securities Market Factors.  In recent years, the securities markets
have  experienced  a high  level of volume  volatility.  Market  prices for many
companies,  particularly small and emerging growth companies, which trade in the
over-the-counter  market,  have been subject to wide fluctuations in response to
quarterly  variations in operating results.  The fluctuations in many cases were
unrelated to the performance of, or announcements concerning, the issuers of the
affected stock.  Thus,  factors such as  announcements  by us or our competitors
concerning any of the following may have a significant  impact on the market for
our securities:

              -    technological innovations
              -    new products or procedures
              -    government regulations and developments
              -    disputes relating to proprietary rights
              -    the acquisition or sale of a business or assets

General market price declines or market volatility in the future could adversely
affect the price of our securities.

         20.  "Penny  Stock"  Regulations  May Impose  Certain  Restrictions  on
Marketability  of  Securities.  The  Commission  has adopted  regulations  which
generally define "penny stock" to be any equity security that has a market price
of less than $5.00 per share.  Our Common Stock currently trades below $5.00 per
share.  The Common Stock offered by this  Prospectus is authorized for quotation
on the Nasdaq SmallCap  Market;  therefore,  it is exempt from the definition of
"penny stock".  However,  if the Common Stock offered hereby is removed from the
SmallCap  Market at any time,  then,  based on the current  market  price of our
Common Stock, it will be subject to rules that impose  additional sales practice
requirements.  For transactions  covered by these rules, the broker-dealer  must
make a special  suitability  determination  for the purchase of the Common Stock
and must have received the purchaser's  written consent to the transaction prior
to the purchase. The "penny stock" rules also require the delivery, prior to the
transaction,  of a risk disclosure  document mandated by the Commission relating
to the  penny  stock  market.  The  broker-dealer  must  also  disclose  (a) the
commission payable to both the broker-dealer and the registered  representative,
(b) current  quotations for the securities,  and (c) if the broker-dealer is the
sole  market  maker,  the   broker-dealer   must  disclose  this  fact  and  the
broker-dealer's  presumed control over the market.  Finally,  monthly statements
must be sent disclosing recent price information for the penny stock held in the
account and information on the limited market in penny stocks. These rules would
apply to sales by broker-dealers to persons other than established customers and
accredited  investors  (generally  those with assets in excess of  $1,000,000 or
annual income exceeding $200,000, or $300,000 together with their spouse), until
our Common Stock trades above $5.00 per share.  Consequently,  the "penny stock"
rules may restrict the ability of  broker-dealers  to sell our Common Stock, and
may affect the ability to sell our Common Stock in the secondary  market as well
as the price at which
    

                                       14

<PAGE>



   
such sales can be made.  Also,  some  brokerage  firms will decide not to effect
transactions  in "penny  stocks" and it is unlikely  that any bank or  financial
institution will accept "penny stock" as collateral.

         21. No Dividends.  We have never paid any dividends on our Common Stock
and do not intend to in the  foreseeable  future.  We  anticipate  retaining any
earnings which we may realize in the foreseeable future to finance our growth.

         22. Limitations on Director Liability. Our Certificate of Incorporation
provides  that  a  director  shall  not  be  personally  liable  to  us  or  our
stockholders  for monetary  damages for breach of fiduciary  duty as a director,
with certain exceptions. These provisions may discourage stockholders from suing
a  director  for breach of  fiduciary  duty and may  reduce  the  likelihood  of
derivative  lawsuits  against any director.  (A  "derivative  lawsuit" is one in
which a stockholder  sues an officer or director of the corporation on behalf of
the  corporation,  claiming  that the officer or  director  did some harm to the
corporation).  In  addition,  our  Certificate  of  Incorporation  provides  for
mandatory  indemnification  of  directors  and  officers to the  fullest  extent
permitted or not prohibited by Delaware law.
    

                              SELLING STOCKHOLDERS

   
         Of the 2,007,517 Shares being offered hereby,  (i) 1,300,000 Shares are
issuable  upon  conversion  of, or  otherwise  with  respect to, 3,250 shares of
Series A Stock held by JNC Opportunity Fund, Ltd. ("Opportunity");  (ii) 327,103
Shares are issuable  upon  conversion  of 1,750 shares of Series B Stock held by
JNC Strategic Fund, Ltd.  ("Strategic" and together with  Opportunity,  the "JNC
Selling  Stockholders");  (iii) 180,414 Shares are issuable upon the exercise of
the Warrants  held by the JNC Selling  Stockholders;  (iv) 75,000  Shares may be
issuable    to   the   JNC    Selling    Stockholders    pursuant   to   certain
registration-related  rights the  Company  has agreed in  principle  to grant to
them;  and (v) 125,000 Shares are owned by three other  individuals  (the "Other
Selling  Stockholders").  The  Series  A Stock  was  issued  by the  Company  to
Opportunity  and the  Warrants  were  issued by the  Company to the JNC  Selling
Stockholders  on June 5,  1998  in a  private  transaction  (the  "1998  Private
Placement").  The Series B Stock was issued by the  Company to  Strategic  as of
September  25, 1998 in  connection  with the 1998 Private  Placement.  The Other
Selling  Stockholders  acquired their  respective  Shares in non-issuer  private
transactions.

         In connection with the 1998 Private Placement,  the Company granted the
JNC  Selling  Stockholders  certain  registration  rights  pursuant to which the
Company agreed to keep the Registration Statement, of which this Prospectus is a
part, effective until the earlier of (i) the date that all of their above Shares
have been sold  pursuant to the  Registration  Statement,  or (ii) the date upon
which such Shares may be immediately sold to the public without  registration or
restriction  pursuant to Rule 144(k)  promulgated  under the  Securities  Act of
1933, as amended (the "Securities Act"). The Company has agreed to indemnify the
JNC  Selling  Stockholders  and  each of  their  officers,  directors,  members,
employees,  partners,  agents  and each  person who  controls  either of the JNC
Selling  Stockholders  against certain  expenses,  claims,  losses,  damages and
liabilities   (or  action,   proceeding   or  inquiry  by  any   regulatory   or
self-regulatory organization in respect thereof). The
    

                                       15

<PAGE>



Company  has agreed to pay its  expenses  of  registering  the Shares  under the
Securities  Act,  including  registration  and filing fees,  blue sky  expenses,
printing expenses,  accounting fees, administrative expenses and its own counsel
fees.

   
         The  following  table sets forth the name of each Selling  Stockholder,
the number of shares of Common Stock of the Company  beneficially  owned by such
Selling  Stockholder  as of  November  15,  1998 and the number of Shares  being
offered by such Selling  Stockholder.  The Shares being offered hereby are being
registered to permit public secondary trading,  and the Selling Stockholders may
offer all or part of the  Shares  for resale  from time to time.  However,  such
Selling  Stockholders are under no obligation to sell all or any portion of such
Shares  nor  are  such  Selling  Stockholders   obligated  to  sell  any  Shares
immediately  under  this  Prospectus.  All  information  with  respect  to share
ownership has been  furnished by the Selling  Stockholders.  Because the Selling
Stockholders may sell all or part of their Shares,  no estimates can be given as
to the  number  of  Shares  that will be held by any  Selling  Stockholder  upon
termination of any offering made hereby. See "Plan of Distribution."
    

         In the case of the Shares  underlying the Series A Stock, the number of
Shares offered for sale hereby represents an estimate of the number of shares of
Common Stock  issuable  upon  conversion  of, or otherwise  with respect to, the
Series A Stock,  based on 200% of the number of shares of Common Stock  issuable
at a conversion  price of $5.00 per share. In the case of the Shares  underlying
the  Warrants,  the  number of Shares  offered  for sale  hereby  represents  an
estimate of the number of shares of Common Stock  issuable  upon exercise of the
Warrants  based on 200% of the number of shares of Common  Stock  issuable at an
exercise  price of $8.025 per share.  Pursuant to Rule 416 under the  Securities
Act,  the JNC Selling  Stockholders  may also offer and sell Shares  issued with
respect to the  Series A Stock,  the Series B Stock  and/or  the  Warrants  as a
result of stock splits,  stock  dividends or similar  transactions.  This is not
intended to  constitute a  prediction  as to the number of Shares into which the
Series A Stock or  Series B Stock  will be  converted  or the  Warrants  will be
exercised.

<TABLE>

   
- -------------------------------------------------------------------------------------------------------------------------------
                                          Shares Beneficially           Shares to be              
Name of Selling Stockholder               Owned Prior to the            Sold in the              Shares Owned after
                                          Offering                      Offering                 the Offering (1)
- -------------------------------------------------------------------------------------------------------------------------------
<S>                                               <C>                      <C>                                <C> 
JNC Opportunity Fund, Ltd.(2)                      141,686(3)               1,463,744(3)(4)                    0
- -------------------------------------------------------------------------------------------------------------------------------
JNC Strategic Fund, Ltd.(2)                        141,686(3)                 418,773(3)(4)                    0
- -------------------------------------------------------------------------------------------------------------------------------
Edwin J. Gerstley                                    62,500                     62,500                         0
- -------------------------------------------------------------------------------------------------------------------------------
Gusti Gross                                          54,500                     54,500                         0
- -------------------------------------------------------------------------------------------------------------------------------
Sidney Blumenthal                                     8,000                      8,000                         0
- -------------------------------------------------------------------------------------------------------------------------------
    

</TABLE>

                                                        16

<PAGE>



         (1)      Assumes all Shares offered hereby are sold in the Offering.

   
         (2)      Opportunity  and  Strategic are the  beneficial  owners of the
                  Shares  to be sold by them  hereunder.  They do not  hold  the
                  Shares  as  nominees  for any  other  person.  Encore  Capital
                  Management, L.L.C. ("Encore"), a registered investment adviser
                  under the Investment  Advisers Act of 1940, acts as investment
                  adviser to, and manager of,  Opportunity and Strategic.  James
                  Q. Chau and Neil T. Chau are the managing members of Encore.

         (3)      The  number  of  "Shares   Beneficially  Owned  Prior  to  the
                  Offering" for each of Opportunity  and Strategic  equals 4.99%
                  of the outstanding  Common Stock of the Company as of November
                  15, 1998.  Pursuant to the terms of the Series A Stock, Series
                  B Stock  and the  Warrants,  the  shares of Series A Stock and
                  Series B Stock and the Warrants are currently  convertible  or
                  exercisable  by any holder  only to the extent that the number
                  of shares of Common Stock thereby issuable,  together with the
                  number of shares of Common  Stock owned by such holder and its
                  affiliates   (but  not   including   shares  of  Common  Stock
                  underlying  unconverted  shares of Series A Stock and Series B
                  Stock or  unexercised  portions  of the  Warrants)  would  not
                  exceed  4.99%  of  the  then   outstanding   Common  Stock  as
                  determined  in  accordance  with Section 13(d) of the Exchange
                  Act.  The  holders of the  Series A Stock,  Series B Stock and
                  Warrants may waive such restriction upon not less than 61 days
                  notice.  Therefore,  the number of shares set forth herein and
                  which a JNC  Selling  Stockholder  may sell  pursuant  to this
                  Prospectus (as provided for in footnote (3) hereof) may exceed
                  the  number  of  shares  such  JNC  Selling   Stockholder  may
                  beneficially  own as  determined  pursuant to Section 13(d) of
                  the Exchange Act.

         (4)      The  number  of  "Shares  to be  Sold  in  the  Offering"  for
                  Opportunity  includes  an  estimate of the number of shares of
                  Common  Stock that would be issuable  upon  conversion  of, or
                  otherwise with respect to, the Series A Stock based on 200% of
                  the number of shares of Common Stock that would be issuable at
                  a conversion price of $5.00 per share (1,300,000  shares).  In
                  addition,  the  Registration  Statement  covers 327,103 shares
                  that are issuable to Strategic upon conversion of the Series B
                  Stock.  Further,  the  number  of  "Shares  to be  Sold in the
                  Offering"  for the JNC Selling  Stockholders  includes  (A) an
                  estimate of the number of shares of Common Stock that would be
                  issuable  upon the exercise of the  Warrants  based on 200% of
                  the number of shares of Common Stock that would be issuable at
                  an  exercise  price of $8.025  per share  (114,994  shares for
                  Opportunity  and 65,420 shares for  Strategic)  and (B) 75,000
                  shares of Common  Stock that may be issuable to them  pursuant
                  to certain  registration-related  rights  that the Company has
                  agreed  in  principle  to grant  to them  (48,750  shares  for
                  Opportunity  and  26,250  shares  for  Strategic).  The actual
                  number of shares of Common Stock  issuable upon  conversion of
                  the  Series A Stock is  determined  by a formula  based on the
                  market  price  at the  time of  conversion,  and is  therefore
                  subject to  adjustment  and could be  materially  less or more
                  than such
    

                                       17

<PAGE>



                  estimated   number   depending  on  factors  which  cannot  be
                  predicted by the Company. Specifically, at any given time, the
                  Series  A Stock is  convertible  into a number  of  shares  of
                  Common  Stock  determined  by dividing  (X) the sum of (a) the
                  stated value of the Series A Stock, (b) a premium amount equal
                  to 5% (on an  annualized  basis)  of the  stated  value of the
                  Series  A Stock  and (c) any  Conversion  Default  amount  (as
                  defined in the  Certificate of  Designations,  Preferences and
                  Rights  for the  Series A Stock),  by (Y) the then  applicable
                  conversion  price  (calculated  generally as the lesser of (i)
                  $8.025  and (ii)  85% of the  average  of the five (5)  lowest
                  closing  bid  prices of the Common  Stock for the  twenty-five
                  (25) consecutive  trading date immediately  preceding the date
                  of  determination)  (such 85%  calculation as of June 5, 1998,
                  the date of  issuance  of the Series A Stock,  resulting  in a
                  conversion  price of $5.6525  per  share),  subject to certain
                  restrictions and  adjustments.  The number of shares of Common
                  Stock  issuable  upon  exercise of the  Warrants is subject to
                  increase to the extent the exercise price is reduced  pursuant
                  to the  antidilution  adjustment  provisions  set forth in the
                  Warrants.  The Shares  offered  hereby,  and  included  in the
                  Registration  Statement  of which this  Prospectus  is a part,
                  include  such  additional  number of shares of Common Stock as
                  may be issued or  issuable  upon  conversion  of the  Series A
                  Stock or Series B Stock or upon  exercise  of the  Warrants by
                  reason  of  any  stock  split,   stock   dividend  or  similar
                  transaction  involving the Common Stock, in each case in order
                  to prevent dilution, in accordance with Rule 416. In the event
                  the number of shares of Common Stock issuable upon  conversion
                  of the Series A Stock or upon exercise of the Warrants exceeds
                  the number of Shares included in the  Registration  Statement,
                  an  additional  Registration  Statement  would be  required to
                  cover the excess.

         To  the  Company's  knowledge,  no  Selling  Stockholder  has  had  any
position,  office or other material  relationship with the Company or any of its
affiliates  during the past three years (other than as a holder of the Company's
securities).

                                 USE OF PROCEEDS

         All the Shares  offered hereby are being offered for the account of the
Selling Stockholders.  Accordingly, the Company will not receive any proceeds of
any sales made  hereunder,  but will receive the exercise  price of any Warrants
exercised  by  the  JNC  Selling  Stockholders.  Based  on  currently  available
information,  the Company  intends to utilize  any  proceeds  received  from the
exercise of Warrants for working  capital and general  corporate  purposes.  The
Company may use all or a portion of such proceeds for other  purposes,  should a
reapportionment  or  redirection  of  funds  be  determined  to be in  the  best
interests of the Company.

                              PLAN OF DISTRIBUTION

         The Shares may be sold or distributed  from time to time by the Selling
Stockholders or by pledgees, donees or transferees of, or successors in interest
to, the Selling Stockholders directly to

                                       18

<PAGE>



one or more  purchasers  (including  pledgees)  or through  brokers,  dealers or
underwriters  who may act solely as agents or may acquire  Shares as principals,
at market  prices  prevailing  at the time of sale,  at prices  related  to such
prevailing market prices, at negotiated prices or at fixed prices,  which may be
changed.  The  distribution  of the Shares may be effected in one or more of the
following methods: (i) ordinary brokers transactions,  which may include long or
short sales, (ii) purchases by brokers, dealers or underwriters as principal and
resale by such  purchasers for their own accounts  pursuant to this  Prospectus,
(iii) "at the market" to or through market makers or into an existing market for
the Common Stock,  (iv) in other ways not involving market makers or established
trading markets,  including direct sales to purchasers or sales effected through
agents, (v) through transactions in options, swaps or other derivatives (whether
exchange listed or otherwise),  or (vi) any combination of the foregoing,  or by
any other legally  available  means.  In addition,  the Selling  Stockholders or
their  successors  in  interest  may  enter  into  hedging   transactions   with
broker-dealers  who may engage in short  sales of shares of Common  Stock in the
course of hedging the positions they assume with the Selling  Stockholders.  The
Selling  Stockholders or their successors in interest may also enter into option
or other  transactions  with  broker-dealers  that require that delivery by such
broker-dealers of the Shares,  which Shares may be resold thereafter pursuant to
this Prospectus.

         Brokers,   dealers,   underwriters  or  agents   participating  in  the
distribution  of the Shares may receive  compensation  in the form of discounts,
concessions or commissions from the Selling  Stockholders  and/or the purchasers
of Shares for whom such broker-dealers may act as agent or to whom they may sell
as principal,  or both (which compensation as to a particular  broker-dealer may
be in  excess  of  customary  commissions).  The  Selling  Stockholders  and any
broker-dealers acting in connection with the sale of the Shares hereunder may be
deemed to be underwriters  within the meaning of Section 2(11) of the Securities
Act, and any commission  received by them and any profit realized by them on the
resale of Shares as principals may be deemed underwriting compensation under the
Securities  Act.  Neither the Company nor any Selling  Stockholder can presently
estimate  the amount of such  compensation.  The  Company  knows of no  existing
arrangements  between any Selling Stockholder and any such stockholder,  broker,
dealer, underwriter or agent relating to the sale or distribution of the Shares.

         Each  Selling  Stockholder  and any  other  person  participating  in a
distribution  of  securities  will be subject to  applicable  provisions  of the
Exchange  Act and the  rules  and  regulations  thereunder,  including,  without
limitation,  Regulation M, which may restrict  certain  activities of, and limit
the timing of purchases and sales of securities  by,  Selling  Stockholders  and
other persons participating in a distribution of securities.  Furthermore, under
Regulation M, persons  engaged in a  distribution  of securities  are prohibited
from simultaneously  engaging in market making and certain other activities with
respect  to  such  securities  for a  specified  period  of  time  prior  to the
commencement  of  such  distributions,   subject  to  specified   exceptions  or
exemptions.  All of the foregoing may affect the marketability of the securities
offered hereby.

         Any  securities  covered  by this  Prospectus  that  qualify  for  sale
pursuant to Rule 144 under the Securities Act may be sold under that Rule rather
than pursuant to this Prospectus.


                                       19

<PAGE>



         There can be no assurance that the Selling  Stockholders  will sell any
or all of the shares of Common Stock offered by them hereunder.

                                  LEGAL MATTERS

         Certain  matters  relating  to the  legality  of the  securities  being
offered hereby are being passed upon for the Company by Certilman  Balin Adler &
Hyman, LLP, 90 Merrick Avenue, East Meadow, New York 11554.

                                     EXPERTS

         The consolidated  financial  statements of the Company appearing in the
Form  10-KSB,  have  been  audited  by Lazar  Levine & Felix,  LLP,  independent
auditors, as set forth in their report thereon included therein and incorporated
herein by reference.  Such  consolidated  financial  statements are incorporated
herein by  reference in reliance  upon such report  given upon the  authority of
such firm as experts in accounting and auditing.

                             ADDITIONAL INFORMATION

         The Company has filed a  Registration  Statement on Form S-3  (together
with all amendments thereto,  the "Registration  Statement") with the Commission
under the  Securities Act with respect to the securities  offered  hereby.  This
Prospectus does not contain all of the information set forth in the Registration
Statement.  For  further  information  with  respect  to  the  Company  and  the
securities offered hereby,  reference is made to the Registration  Statement and
to the exhibits filed therewith, copies of which may be obtained upon payment of
a fee  prescribed  by the  Commission,  or may be examined free of charge at the
public reference facilities maintained by the Commission at Judiciary Plaza, 450
Fifth  Street,  N.W.,  Washington,  D.C.  20549.  Each  statement  made  in this
Prospectus  referring  to a document  filed as an  exhibit  to the  Registration
Statement is  qualified by reference to the exhibit for a complete  statement of
its terms and conditions.


                                       20

<PAGE>




                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.  Other Expenses of Issuance and Distribution.

         The following table sets forth the expenses  (estimated  except for the
Registration Fee) in connection with the offering  described in the Registration
Statement:

   
 Registration Fee...................................................$    906.00
 Accountants' Fees and Expenses.....................................   1,000.00
 Legal Fees and Expenses............................................. 12,000.00
 Miscellaneous......................................................   1,094.00

 Total...............................................................$15,000.00
    

Item 15.  Indemnification of Directors and Officers.

         Article X of the Company's Certificate of Incorporation  eliminates the
personal liability of directors to the Company and its stockholders for monetary
damages  for  breach of  fiduciary  duty as a  director  to the  fullest  extent
permitted by Section 102 of the Delaware General  Corporation Law, provided that
this provision  shall not eliminate or limit the liability of a director (i) for
any breach of the director's duty of loyalty to the Company or its stockholders,
(ii) for acts or  omissions  not in good  faith  or  which  involve  intentional
misconduct or a knowing violation of law, (iii) arising under Section 174 of the
Delaware General Corporation Law (with respect to unlawful dividend payments and
unlawful stock purchases or redemptions), or (iv) for any transaction from which
the director derived an improper personal benefit.

         Additionally,   the  Company  has  included  in  its   Certificate   of
Incorporation and its by-laws  provisions to indemnify its directors,  officers,
employees and agents and to purchase insurance with respect to liability arising
out of the  performance  of their duties as directors,  officers,  employees and
agents as permitted by Section 145 of the Delaware General  Corporation Law. The
Delaware  General  Corporation  Law provides  further  that the  indemnification
permitted  thereunder shall not be deemed exclusive of any other rights to which
the  directors,  officers,  employees  and  agents  may be  entitled  under  the
Company's by-laws, any agreement, vote of stockholders or otherwise.

         The effect of the  foregoing  is to require  the  Company to the extent
permitted by law to indemnify the officers,  directors,  employees and agents of
the  Company  for any claim  arising  against  such  persons  in their  official
capacities if such person acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the Company, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe
his conduct was unlawful.


                                      II-1

<PAGE>




         In  connection  with  this  Registration  Statement,  the  JNC  Selling
Stockholders,  severally but not jointly,  have agreed to indemnify the Company,
its directors,  each of its officers who signed this Registration Statement, its
employees,  agents and each person who controls it within the meaning of Section
15 of the  Securities  Act with respect to any statement in or omission from the
Registration  Statement or the Prospectus or any amendment or supplement thereto
if such statement or omission was made in reliance upon information furnished in
writing to the Company by the JNC Selling  Stockholders  specifically for use in
connection with the preparation of the Registration Statement.  Each JNC Selling
Stockholder's  indemnification  obligations  are  limited to the amount such JNC
Selling  Stockholder  actually  receives  as a result of the sale of the  shares
registered for resale hereunder.

         Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors,  officers or persons  controlling the Company
pursuant to the foregoing provisions, the Company has been informed that, in the
opinion of the  Securities  and Exchange  Commission,  such  indemnification  is
against  public  policy as  expressed  in the  Securities  Act and is  therefore
unenforceable.

Item 16.  Exhibits.

Exhibit Number            Description of Exhibit

           4              Specimen Stock Certificate1

           5              Opinion of Certilman Balin Adler & Hyman, LLP

         23.1             Consent of Lazar Levine & Felix, LLP

         23.2             Consent of Certilman Balin Adler & Hyman, LLP 
                         (included in its opinion filed as Exhibit 5)

         24               Powers of Attorney (included in signature page forming
                          a part hereof).

         -----------

         (1)      Filed as Exhibit 4.1 to the Company's  Registration  Statement
                  on Form SB-2  (Registration  No.  333-18667) and  incorporated
                  herein by reference.

Item 17.  Undertakings.

         The undersigned Company hereby undertakes:

                  (l) To file,  during any  period in which  offers or sales are
being made, a post-effective amendment to this Registration Statement to:

                                      II-2

<PAGE>




               (i) Include any  Prospectus  required by Section  10(a)(3) of the
          Securities Act;

               (ii)  Reflect  in the  Prospectus  any  facts  or  events  which,
          individually  or  together  represent  a  fundamental  change  in  the
          information set forth in the Registration  Statement;  notwithstanding
          the  foregoing,  any  increase  or  decrease  in volume of  securities
          offered (if the total dollar value of the securities offered would not
          exceed that which was  registered)  and any deviation  from the low or
          high end of the estimated  maximum  offering range may be reflected in
          the form of  prospectus  filed with the  Commission  pursuant  to Rule
          424(b) if, in the aggregate, the changes in volume and price represent
          no more than a 20 percent  change in the  maximum  aggregate  offering
          price set forth in the "Calculation of Registration  Fee" table in the
          effective Registration Statement; and

               (iii) Include any additional or changed  material  information on
          the plan of distribution;  provided,  however,  that paragraphs (l)(i)
          and (l)(ii) do not apply if the Registration  Statement is on Form S-3
          or  Form  S-8,  and  the  information  required  in  a  post-effective
          amendment is incorporated by reference from periodic  reports filed by
          the Company under the Exchange Act.

                  (2) For  determining  any liability  under the Securities Act,
treat each  post-effective  amendment  as a new  Registration  Statement  of the
securities  offered,  and the offering of the  securities at that time to be the
initial bona fide offering.

                  (3)  File  a  post-   effective   amendment   to  remove  from
registration  any of the securities  being registered which remain unsold at the
end of the offering.

         Insofar as indemnification for liabilities arising under the Securities
Act may be  permitted to  directors,  officers  and  controlling  persons of the
Company pursuant to the provisions  described under Item 15 above, or otherwise,
the Company has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against such liabilities (other than the payment by the Company
of expenses incurred or paid by a director, officer or controlling person of the
Company in the successful defense of any action, suit or proceeding) is asserted
by  such  director,  officer  or  controlling  person  in  connection  with  the
securities  being  registered,  the Company  will,  unless in the opinion of its
counsel the matter has been settled by controlling precedent,  submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against public policy as expressed in the Securities Act and will be governed by
the final adjudication of such issue.



                                      II-3

<PAGE>



                                   SIGNATURES

   
         Pursuant to the requirements of the Securities Act of 1933, the Company
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for filing on Form S-3 and has duly caused this  amendment  to its
Registration Statement to be signed on its behalf by the undersigned,  thereunto
duly authorized, in Cedarhurst, New York, on the 20th day of November, 1998.
    

                                                  COMPU-DAWN, INC.


   
                                                  By:/s/ Mark Honigsfeld
                                                     Mark Honigsfeld
                                                     Chief Executive Officer and
                                                     Chairman of the Board
    

                                 -------------

         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Registration  Statement  has been signed below by the  following  persons in the
capacities and on the dates indicated.

Signature                         Capacity                            Date 

   
       *                    Chief Executive Officer,          November 20, 1998
- -----------------           Chairman of the Board,
Mark Honigsfeld             Secretary and Director
                            (Principal Executive Officer and
                            Principal Financial and
                            Accounting Officer)

       *                                          
- -----------------           Chief Technology Officer          November 20, 1998
Louis Libin                 and Director


        *                   Director                          November 20, 1998
- -------------------
William D. Rizzardi

        *                   Director                          November 20, 1998
- -------------------
Harold Lazarus, Ph.D.

        *                    Director                         November 20, 1998
- -------------------
Alfred J. Luciani
    


<PAGE>


   
* Mark  Honigsfeld,  pursuant  to Powers of  Attorney  (executed  by each of the
persons  listed  above  and  indicated  as  signed  above,  and  filed  with the
Securities and Exchange Commission), by signing his name hereto does hereby sign
and execute this  amendment to the  Registration  Statement on behalf of each of
the persons  named above and  indicated as signing  above in the  capacities  in
which the names of each appear  above,  and does  hereby  sign and execute  this
amendment  to the  Registration  Statement  in his own behalf in the capacity of
Chief Executive Officer, Chairman of the Board, Secretary and Director.



November 20, 1998                                        /s/ Mark Honigsfeld 
                                                        Mark Honigsfeld
    

                                      II-5

<PAGE>






                                                                 Exhibit 5





                                                              November 20, 1998


Compu-DAWN, Inc.
77 Spruce Street
Cedarhurst, NY 11516

                  Re: Compu-DAWN, Inc. Registration Statement on Form S-3

Gentlemen:

         In our capacity as counsel to Compu-DAWN,  Inc., a Delaware corporation
(the  "Company"),  we have been asked to render this opinion in connection  with
Amendment   No.  1  to  the  Company's   Registration   Statement  on  Form  S-3
(Registration  No.  333-65303)  (the   "Registration   Statement")  being  filed
contemporaneously  by the Company with the  Securities  and Exchange  Commission
under the  Securities  Act of 1933, as amended,  covering an  additional  75,000
shares of Common Stock, $.01 par value, of the Company which are issuable by the
Company to certain entities pursuant to certain  registration-related rights the
Company  has agreed in  principle  to grant to such  entities  (the  "Additional
Shares") and are being registered for resale by such entities.

         In connection  with our opinion,  we have examined the  Certificate  of
Incorporation and By-Laws of the Company,  each as amended, and the Registration
Statement.  We are also familiar with  proceedings  of the Board of Directors of
the Company, or otherwise have relied upon  representations  made by officers of
the Company,  relating to the  authorization  of the issuance of the  Additional
Shares.  We have also examined such other instruments and documents as we deemed
relevant under the circumstances.

         For purposes of the opinions  expressed  below, we have assumed (i) the
authenticity of all documents submitted to us as originals,  (ii) the conformity
to the  originals  of all  documents  submitted  as  certified,  photostatic  or
facsimile copies and the authenticity of the originals, (iii) the legal capacity
of natural persons,  (iv) the due  authorization,  execution and delivery of all
documents by all parties and the validity and binding effect thereof and (v) the
conformity to the  proceedings  of the Board of Directors of all minutes of such
proceedings and all representations,  oral and written,  made by officers of the
Company with respect thereto. We have also assumed that the


<PAGE>


Compu-DAWN,  Inc.  November 20, 1998 Page 2 corporate records furnished to us by
the Company include all corporate proceedings taken by the Company to date.

         Based upon and  subject to the  foregoing,  including  the  assumptions
made,  we are of the opinion that the  Additional  Shares will be, upon issuance
pursuant to certain  registration-related rights which the Company has agreed in
principle  to grant,  duly and validly  authorized  and  issued,  fully paid and
nonassessable shares of Common Stock, $.01 par value, of the Company.

         We hereby  consent to the use of our  opinion as herein set forth as an
exhibit  to the  Registration  Statement  and to the use of our name  under  the
caption  "Legal  Matters" in the Prospectus  forming a part of the  Registration
Statement.

         This opinion is as of the date  hereof,  and we do not  undertake,  and
hereby  disclaim,  any  obligation  to advise  you of any  changes in any of the
matters set forth herein.

         We are  rendering  this  opinion only as to the matters  expressly  set
forth herein, and no opinion should be inferred as to any other matters.

         This opinion is for your  exclusive  use only and is to be utilized and
relied upon only in connection with the matters expressly set forth herein.


                                         Very truly yours,

                                         /s/ Certilman Balin Adler & Hyman, LLP

                                         CERTILMAN BALIN ADLER & HYMAN, LLP


<PAGE>



                        CONSENT OF INDEPENDENT CERTIFIED
                               PUBLIC ACCOUNTANTS

We hereby consent to the  incorporation  by reference in this Amendment No. 1 to
the Registration Statement on Form S-3 of our report dated March 5, 1998 (except
as to Note 13c which is dated March 17,  1998) which  appears on page F-1 of the
annual  report on Form 10-KSB of Compu- DAWN,  Inc. for the year ended  December
31, 1997 and to the  reference  to our firm under the caption  "Experts"  in the
prospectus.

                                   /s/ Lazar Levine & Felix, LLP               


New York, New York
November 20, 1998
 




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission